Partnering Solutions

  1. Worldwide Clinical Trials Phase I Service Provider Performance Profile

    An excerpt taken directly from CRO Quality Benchmarking - Phase I Service Providers report, June 2018.

  2. Adapting And Evolving In An Era Of Biologic Growth

    Learn how Q2 Solutions continues to advance their customers' efforts and lead the way in the evolving science and regulatory environment.

  3. Advancing Precision Medicine Through Anatomic Pathology

    Tissue-based molecular testing and companion diagnostics

  4. Assays To Drive Success In Anti-infective And Vaccine Development

    Learn how Q2 Solutions utilizes over 35 years of experience in infectious disease and immunology assay development and clinical diagnostic testing to provide you with solutions to meet your anti-infective and vaccine needs across the development continuum.

  5. Delivery Excellence For Anti-infective And Vaccine Development

    Learn more about how Q2 Solutions is providing best-in-class quality systems across a global vaccine network to ensure sample integrity for high-quality data delivery and better outcomes for your anti-infective or vaccine study.

  6. Q2 Comprehensive Sample Management Innovations

    Keep track of specimens collected, stored, shipped, tested and reported through innovative laboratory sample management .

  7. Q2 Laboratory Network Solutions

    Realize cost savings, faster contracting and simplified study data by centralizing your lab delivery and management with a proven lab services provider.

  8. Q2 Solutions CRO Partnership Model

    A comprehensive solution that streamlines the CRO plus clinical laboratory service model from start to finish.

  9. A Biomarker-Driven Approach To Developing Targeted Therapies

    Determine the steps to a successful biomarker strategy that will drive your precision medicines across the drug development continuum.

  10. Companion Diagnostic Expertise

    Learn more about how Q2 Solutions provides customers an optimal path to co-develop their companion diagnostic with clinical development of the therapeutic, regulatory submission and market launch.